Bevacizumab injection for chronic subdural hematoma
Treatments studied
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests if injecting bevacizumab into the artery that supplies the covering of the brain can help treat chronic subdural hematoma (a slow-growing collection of blood on the brain's surface). It may offer an alternative to surgery for some patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a chronic subdural hematoma seen on a CT or MRI scan, with blood present for more than 10 days after an injury or event
- The hematoma shows signs of mixed age blood and has membranes around it
- You are not pregnant, breastfeeding, or unwilling to use birth control during the study
- You have no other serious brain conditions (like cancer), no allergies to bevacizumab, and no uncontrolled bleeding or infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a drug called bevacizumab (given through an artery in the brain) to a standard procedure called middle meningeal artery embolization (MMAE) helps treat chronic subdural hematoma (a collection of blood on the brain's surface) better than the procedure alone. The study is for people scheduled for MMAE who meet specific size and symptom criteria.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests if a medication called tranexamic acid can help treat chronic subdural hematomas (a type of bleeding on the brain) without surgery. It's for patients who have this condition but don't need immediate surgery.
This trial compares two ways to treat a chronic subdural hematoma (a long-lasting bleed between the brain and its covering): blocking a specific artery versus standard surgery to remove the blood. It may help you and your care team choose the safer and more effective option for your situation.
This trial tests a new surgery for chronic subdural hematoma, which is a collection of blood on the brain. In addition to standard drainage, doctors will try to stop a key artery from bleeding, which may reduce the chance of the hematoma coming back.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
Hear when a new Chronic Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.